CORAT Therapeutics GmbH develops an innovative therapeutic drug composed of a novel fully human neutralizing antibody against COVID-19, which very efficiently neutralizes SARS-CoV-2 and stops its spread within the human body. Our lead product, COR-101, decreased the virus load in the lung by more than 99 % in the Hamster COVID-19 model, and induced recovery after 2 days, compared to 7 days untreated (more information).
Our go...
CORAT Therapeutics GmbH develops an innovative therapeutic drug composed of a novel fully human neutralizing antibody against COVID-19, which very efficiently neutralizes SARS-CoV-2 and stops its spread within the human body. Our lead product, COR-101, decreased the virus load in the lung by more than 99 % in the Hamster COVID-19 model, and induced recovery after 2 days, compared to 7 days untreated (more information).
Our goal is to realize our vision of an immunotherapeutic remedy for acute COVID-19 as fast as possible. In contrast to any vaccine, such a drug is dedicated to treat and cure COVID-19 infected patients
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.